Novonesis is the combined company following the merger of Chr. Hansen and Novozymes, which was completed in January 2024. (Archive photo). Photo: Liselotte Sabroe/Ritzau Scanpix
Novonesis’s stock had its biggest gain in a Decade
On Thursday, Novonesis topped the Danish C25 index, rising over 10% and heading toward its largest increase in over ten years. Novonesis, formed by the January 2024 merger of Chr. Hansen and Novozymes, published its second-quarter financial report on Wednesday after the market closed.
The...
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?